Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025 Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …
Feature

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

November 3, 2025 Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …
Feature
partnership

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

October 30, 2025 Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership

Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …
News

BioMedX launches R&D accelerator to advance women’s health

October 28, 2025 Research and Development BioMedX, Gates Foundation, Women’s Health

BioMed X, an independent research institute with sites in Germany and the United States, has announced the launch of XFem …
News
drug-trials

THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment

October 23, 2025 Research and Development Neurological Diseases, THX Pharma, Theranexus

THX Pharma (Theranexus), a pharma company focusing on developing treatments for rare neurological disease, and Exeltis, a pharma company within …
News

Chemify relocates to Glasgow’s new Health Innovation Hub

October 17, 2025 Research and Development Chemify, Kadans Science Partner, Scotland

The company will be one of the first tenants in the city’s flagship life sciences facility
News

Oxford North UK innovation district officially opened

October 16, 2025 Research and Development Oxford North, University of Oxford, innovation district

Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly …
News

Symeres appoints Gabriella Gentile as chief operating officer

October 13, 2025 Research and Development Symeres

Symeres, a mid-sized contract research, development and manufacturing organisation (CRDMO), has appointed Gabriella Gentile as its chief operating officer. Operating …
Appointment

Uterine fibroids and the cost of silence

October 9, 2025 Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …
Feature

Recipharm designates Germany site as Centre of Excellence

October 9, 2025 Research and Development CDMO, Cuxhaven, Recipharm, biologics

The multi-product facility recently underwent significant renovations
News

Esaote presents new MRI system to support brain glioma surgeries

October 7, 2025 Research and Development Esaote, MRI, medical imaging, neurology

Gliomas are among the most common primary malignant brain tumours
News
drug-trials

Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits

October 6, 2025 Research and Development Bio-Rad, Diagnostics and Testing, Gencurix, oncology

The agreement expands access to oncology testing kits across Europe
News

The Pharma Files: With Colin Williams from Astellas Pharma

October 5, 2025 Medical Communications, Research and Development Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …
Feature

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

October 3, 2025 Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds
Feature

Micrima announces upcoming launch of new UK breast cancer assessment

October 3, 2025 Research and Development Micrima, breast cancer, oncology

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026